Alpha-Glucosidase Inhibitors And Methods of Their Use Read more about Alpha-Glucosidase Inhibitors And Methods of Their Use US Application 61/409,697Filed on 2010-11-03
Substituted Pyrazolopyrimidines As Glucocerebrosidase Activators Read more about Substituted Pyrazolopyrimidines As Glucocerebrosidase Activators US Application 61/420,946Filed on 2010-12-08
Methods of Treating Giardiasis Read more about Methods of Treating Giardiasis US Application 61/411,509Filed on 2010-11-09
Compounds And Methods For The Treatment Of Giardiasis Read more about Compounds And Methods For The Treatment Of Giardiasis US Application 61/392,096Filed on 2010-10-12
Compounds, Pharmaceutical Compositions, And Methods For Treating Or Preventing Lysosomal Storage Diseases Read more about Compounds, Pharmaceutical Compositions, And Methods For Treating Or Preventing Lysosomal Storage Diseases US Application 61/388,434Filed on 2010-09-30
Compounds, Pharmaceutical Compositions, And Methods of Treating Or Preventing Neurodegenerative Diseases Or Disorders Read more about Compounds, Pharmaceutical Compositions, And Methods of Treating Or Preventing Neurodegenerative Diseases Or Disorders US Application 61/388,482Filed on 2010-09-30
HETEROCYCLIC COMPOUNDS AS RORyt MODULATORS AND USES THEREOF Read more about HETEROCYCLIC COMPOUNDS AS RORyt MODULATORS AND USES THEREOF US Application 61/339,974Filed on 2010-03-11
Use Of Delta-tocopherol For The Treatment Of Lysosomal Storage Disorders (LSDs). LSDs Are A Group Of 40 To 50 Genetic Rare Diseases Caused By The Genetic Mutations Of A Number Of Lysosomal Enzymes And Proteins. Read more about Use Of Delta-tocopherol For The Treatment Of Lysosomal Storage Disorders (LSDs). LSDs Are A Group Of 40 To 50 Genetic Rare Diseases Caused By The Genetic Mutations Of A Number Of Lysosomal Enzymes And Proteins. US Application 61/365,712Filed on 2010-07-19
Inhibitors of Human 12-Lipoxygenase Read more about Inhibitors of Human 12-Lipoxygenase US Application 61/345,708Filed on 2010-05-18